Yokohama City University Hospital - Dept of Otorhinolaryngology

Yokohama

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Cancer

Studies at this site

• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early